Ignite Creation Date:
2024-05-06 @ 3:22 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02277197
Status:
COMPLETED
Last Update Posted:
2019-04-18
First Post:
2014-10-25
Brief Title:
Ficlatuzumab and Cetuximab in RecurrentMetastatic Head and Neck Squamous Cell Carcinoma HNSCC
Sponsor:
James J Lee
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
13-059
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
James J Lee
Lead Sponsor Class:
OTHER
Responsible Party:
James J Lee
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AVEO Pharmaceuticals Inc | INDUSTRY |